Financial Services -
Financial - Capital Markets - NASDAQ - US
$ 4.46
0 %
$ 44.4 M
Market Cap
3.15
P/E
1. INTRINSIC VALUE
Balance Sheet
MDB Capital Holdings, LLC Class A common
| Current Assets | 23.6 M |
| Cash & Short-Term Investments | 20.4 M |
| Receivables | 63.8 K |
| Other Current Assets | 3.09 M |
| Non-Current Assets | 48.4 M |
| Long-Term Investments | 38.4 M |
| PP&E | 732 K |
| Other Non-Current Assets | 9.22 M |
| Current Liabilities | 1.19 M |
| Accounts Payable | 324 K |
| Short-Term Debt | 0 |
| Other Current Liabilities | 868 K |
| Non-Current Liabilities | 712 K |
| Long-Term Debt | 712 K |
| Other Non-Current Liabilities | 0 |
EFFICIENCY
Earnings Waterfall
MDB Capital Holdings, LLC Class A common
| Revenue | 2.22 M |
| Cost Of Revenue | 20.1 M |
| Gross Profit | -17.8 M |
| Operating Expenses | 10.8 M |
| Operating Income | -28.6 M |
| Other Expenses | -40.2 M |
| Net Income | 11.6 M |
RATIOS
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
MDB Capital Holdings, LLC Class A common
| Net Income | 11.6 M |
| Depreciation & Amortization | 230 K |
| Capital Expenditures | 546 K |
| Stock-Based Compensation | 14.4 M |
| Change in Working Capital | -2.57 M |
| Others | -35.9 M |
| Free Cash Flow | -8.49 M |
Wall Street Analysts Price Targets
MDB Capital Holdings, LLC Class A common
MDBH has no price targets from Wall Street.
4. DIVIDEND
ANALYSIS
MDBH does not distribute dividends.
5. COMPETITION
6. Ownership
Insider Ownership
MDB Capital Holdings, LLC Class A common
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
53.5 K USD 1
9-12 MONTHS
0 USD 0
Bought
44.7 K USD 1
0-3 MONTHS
57.5 K USD 1
3-6 MONTHS
57.6 K USD 1
6-9 MONTHS
0 USD 0
9-12 MONTHS
7. News
New PatentVest Pulse Report Maps the Competitive and IP Landscape of the $188B Surgical Robotics Market
Designed for investors, board members, and CEOs, the latest PatentVest Pulse reveals who's actually leading and why in one of the most underpenetrated markets in medtech Designed for investors, board members, and CEOs, the latest PatentVest Pulse reveals who's actually leading and why in one of the most underpenetrated markets in medtech
globenewswire.com
- 1 week ago
MDB Capital Holdings Announces Transitions In Its Board of Directors
Matthew Hayden transitions to new strategic role; Dan Torpey appointed Audit Committee Chair Matthew Hayden transitions to new strategic role; Dan Torpey appointed Audit Committee Chair
globenewswire.com
- 1 month ago
New PatentVest Pulse Report Reveals IP Gaps in Billion-Dollar Humanoid Robotics Startups
Despite rising valuations, most humanoid robotics startups remain underprotected—leaving long-term value at risk Despite rising valuations, most humanoid robotics startups remain underprotected—leaving long-term value at risk
globenewswire.com
- 2 months ago
MDB Capital Holdings to Host First Quarter 2025 Results Conference Call on Wednesday May 21, 2025, at 4:30 p.m. Eastern Time
Addison, Texas, May 14, 2025 (GLOBE NEWSWIRE) -- MDB Capital Holdings, LLC, (NASDAQ: MDBH) (“MDB”), a public venture platform focused on launching category-leading disruptive technology companies, plans to host a Zoom webinar on Wednesday May 21, 2025 at 4:30 p.m. Eastern Time to discuss its results for the first quarter 2025. A press release detailing these results will be issued prior to the call.
globenewswire.com
- 2 months ago
Hemostemix Engages PatentVest to Strengthen its Global Patent Portfolio
Calgary, Alberta--(Newsfile Corp. - April 23, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) a leader in the development of autologous stem cell therapy for the treatment of cardiovascular diseases, announces its partnership with PatentVest. PatentVest, a subsidiary of MDB Capital (NASDAQ: MDBH), is a premier intellectual property strategy and patent prosecution firm specializing in life sciences.
newsfilecorp.com
- 2 months ago
MDB Capital Holdings, LLC (MDBH) Q4 2024 Earnings Call Transcript
MDB Capital Holdings, LLC (NASDAQ:MDBH ) Q4 2024 Earnings Conference Call March 31, 2025 4:30 PM ET Company Participants Kevin Cotter – Managing Director-Investment Banking Chris Marlett – Chief Executive Officer and Co-Founder Jeremy James – Chief Financial Officer Gary Schuman – Broker Dealer Chief Financial Officer and Head-Compliance Conference Call Participants Kevin Cotter [Call Starts Abruptly] will follow the formal presentation. If you have questions during the presentation, you can type them into the chat to be answered during the question-and-answer period.
seekingalpha.com
- 3 months ago
New PatentVest Pulse Report Maps the Competitive and IP Landscape of the $400B Brain-Computer Interface (BCI) Market
Designed for investors, board members, and CEOs, the latest PatentVest Pulse offers a strategic view of who's winning—and why—in the emerging BCI market Designed for investors, board members, and CEOs, the latest PatentVest Pulse offers a strategic view of who's winning—and why—in the emerging BCI market
globenewswire.com
- 3 months ago
MDB Capital Holdings to Host Fourth Quarter and Full Year 2024 Results Conference Call on Monday March 31, 2025, at 4:30 p.m. Eastern Time
Addison, TX, March 24, 2025 (GLOBE NEWSWIRE) -- MDB Capital Holdings, LLC, (NASDAQ: MDBH) (“MDB”), a public venture platform focused on launching category-leading deep technology companies, plans to host a Zoom webinar on Monday March 31, 2025 at 4:30 p.m. Eastern Time to discuss its results for the fourth quarter and full year 2024. A press release detailing these results will be issued prior to the call. Christopher Marlett, CEO and Co-Founder of MDB will lead the call and will be joined by other members of the management team to review recent developments, ongoing initiatives, anticipated milestones, as well as host a question-and-answer period. Investors can pre-register now for the Zoom webinar HERE . The live webinar can also be accessed on the day of the event through MDB's investor relations website at https://investors.mdb.com/. About MDB Capital Holdings, LLC Founded in 1997, MDB Capital makes investments that can change lives by discovering and transforming deep technology Big Ideas into valuable public companies through a unique approach to public venture capital. This approach focuses on community-driven financings of pre-revenue, early-stage deep technology companies through early initial public offerings (IPOs), primarily listed on NASDAQ, as well as post-IPO offerings for already public companies that fit MDB's overall investment criteria. MDB Capital is the brand under which MDB Capital Holdings, LLC (NASDAQ: MDBH) and its subsidiaries operate and provide services. This includes MDB Capital, a self-clearing broker-dealer with the MDB Direct trading platform, and PatentVest, the first integrated, intellectual property (IP) intelligence, strategy consulting and IP law firm. MDB Capital is a registered broker-dealer, a member of FINRA and a member of SIPC. For more information, please visit www.mdb.com. Forward-Looking Statements This press release contains "forward-looking statements." These forward-looking statements are made as of the date they were first issued and were based on current expectations, estimates, forecasts and projections as well as the beliefs and assumptions of management. Words such as "expect," "anticipate," "should," "believe," "hope," "target," "project," "goals," "estimate," "potential," "predict," "may," "will," "might," "could," "intend," "shall" and variations of these terms or the negative of these terms and similar expressions are intended to identify these forward-looking statements. Forward-looking statements are subject to a number of risks and uncertainties, many of which involve factors or circumstances that are beyond MDB's control. MDB's actual results could differ materially from those stated or implied in forward-looking statements due to a number of factors, including but not limited to, risks detailed in documents that may be filed by MDB from time to time with the SEC. The forward-looking statements included in this press release represent MDB's views as of the date of this press release. MDB anticipates that subsequent events and developments will cause its views to change. MDB undertakes no intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. These forward-looking statements should not be relied upon as representing MDB's views as of any date subsequent to the date of this press release. Investor Relations Contact: IR@mdb.com Media Contact: press@mdb.com
globenewswire.com
- 3 months ago
New PatentVest Pulse Report Reveals Transformative Trends in the AI Data Center Patent Race
•China accounts for 77% of all AI data center patent filings globally, with five of the top patent holders hailing from China - underlining its dominant position in next-generation AI infrastructure •China accounts for 77% of all AI data center patent filings globally, with five of the top patent holders hailing from China - underlining its dominant position in next-generation AI infrastructure
globenewswire.com
- 4 months ago
eXoZymes Announces Nasdaq Bell Ringing to Commemorate Initial Public Offering
Monrovia, CA, Feb. 19, 2025 (GLOBE NEWSWIRE) -- eXoZymes, Inc. (Nasdaq: EXOZ) (“eXoZymes”) – a pioneer of AI-engineered enzymes that can transform sustainable feedstock into essential chemicals, medicines, and biofuels – today announced that CEO Michael Heltzen will be joined by eXoZymes team members to ring the Nasdaq Stock Market (“Nasdaq”) closing bell on Wednesday, February 19, 2025. This comes following a successful initial public offering of common stock at $8 per share, which closed on November 14, 2024.
globenewswire.com
- 5 months ago
Rebranding Invizyne to eXoZymes Signifies a Sustainable Paradigm Shift in Chemical Production Leveraging AI-Engineered Enzymes
Rebranding Invizyne Technologies, Inc to eXoZymes Inc. Changing NASDAQ ticker from IZTC to EXOZ Introducing but not trademarking “exozymes” as a new scientific nomenclature Monrovia, California, Feb. 12, 2025 (GLOBE NEWSWIRE) -- Today, Invizyne Technologies, Inc. - a pioneer of AI-engineered enzymes that can sustainably transform feedstock into essential chemicals, medicines, and biofuels, announced a corporate name change to eXoZymes, Inc. (“eXoZymes”) and that its common stock will begin trading on the Nasdaq Capital Market under the new ticker symbol of “EXOZ” effective before the market open. No action is required by existing shareholders with respect to the name and ticker symbol change.
globenewswire.com
- 5 months ago
Invizyne Technologies Announces Name Change to eXoZymes, Inc. and New Ticker Symbol
Trading Under New Ticker of “EXOZ” Expected to Begin February 12, 2025 Trading Under New Ticker of “EXOZ” Expected to Begin February 12, 2025
globenewswire.com
- 5 months ago
8. Profile
Summary
MDB Capital Holdings, LLC Class A common MDBH
COUNTRY
US
INDUSTRY
Financial - Capital Markets
MARKET CAP
$ 44.4 M
Dividend Yield
0.00%
Description
MDB Capital Holdings, LLC, through its subsidiaries, primarily operates as a broker-dealer. The company operates through two segments, Broker Dealer & Intellectual Property Service, and Technology Development. The Broker Dealer & Intellectual Property Service segment operates as a full-service broker dealer that focuses on conducting private and public securities offerings, as well as providing research services for investment banking due diligence. The Technology Development segment engages in the synthetic biology technology development business. The company was founded in 1997 and is based in Addison, Texas.
Contact
14135 Midway Road, Addison, DE, 75001
https://www.mdb.com
IPO
Date
Sept. 21, 2023
Employees
16
Officers
Mr. Mohammad Hayat J.D.
Head of Corporate Development, Chief Legal Officer & Director
Mr. Anthony DiGiandomenico
Co-Founder, Head of New Venture Discovery & Director
Mr. George H. Brandon
President & Director
Mr. Jeremy William James
Chief Financial Officer
Mr. Christopher A. Marlett
Co-Founder, Chief Executive Officer & Chairman